• The Walt Disney Company (DIS)
  • View DIS Profile
  • View Questions on DIS
• Pfizer Inc. (PFE)
  • View PFE Profile
  • View Questions on PFE

Q: Hello, I am down on both : PFE and DIS. Based on their business fundamentals, balance sheet and growth, is it time to move on and sell both?
Thanks
Carlo

Upvote 3

Read Answer Asked by Carlo on December 31, 2024

• Pfizer Inc. (PFE)
  • View PFE Profile
  • View Questions on PFE
• Methanex Corporation (MX)
  • View MX Profile
  • View Questions on MX
• ATS Corporation (ATS)
  • View ATS Profile
  • View Questions on ATS
  • View Reports on ATS
• Open Text Corporation (OTEX)
  • View OTEX Profile
  • View Questions on OTEX
• Nutrien Ltd. (NTR)
  • View NTR Profile
  • View Questions on NTR

Q: All of these companies have really high debt levels, could you comment on their prospects and whether you would buy, hold or sell. Thanks!

Upvote 6

Read Answer Asked by Sandy on December 03, 2024

• Gilead Sciences Inc. (GILD)
  • View GILD Profile
  • View Questions on GILD
• AbbVie Inc. (ABBV)
  • View ABBV Profile
  • View Questions on ABBV
• Bristol-Myers Squibb Company (BMY)
  • View BMY Profile
  • View Questions on BMY
• Pfizer Inc. (PFE)
  • View PFE Profile
  • View Questions on PFE
• iShares U.S. Medical Devices ETF (IHI)
  • View IHI Profile
  • View Questions on IHI

Q: Your thoughts on keeping three out of 5 pharma names: ETF IHI, Gilead Sciences, Bristol Meyers, Abbvie and just bought Pfeizer few weeks ago - hopeful on the Seagen purchase in 2023. I have room only for 3,

Thank you!

Upvote 2

Read Answer Asked by Nhung on November 27, 2024